The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
To 'Post Your News' use the button at the top right.
We are pleased to present below all posts archived in 'February 2020'. If you still can't find what you are looking for, try using the search box.
Life sciences was a major source of deal activity for Fieldfisher in 2019, with three of the firm's four IPOs completed for clients in this sector. The firm also assisted a number of fast-growing businesses, principally in the biotech space, in successfully raising funds in the London and Paris markets to develop treatments and expand into new markets.
Read the rest of entry »
OXFORD, UK – 10th February 2020 – Arctoris Ltd has announced a formal partnership with Molecule in order to tackle the ongoing innovation crisis faced by drug discovery and development across both industry and academia.
ULT or ultra-low temperature sample freezers are found in bio-banks and labs everywhere. But few people know the impact these freezers have on both the environment and your wallet.
A new funding opportunity – Artificial Intelligence in Health and Care Award has been launched, with £140 million over 3 years, to fund and accelerate the testing and evaluation of the most promising AI technologies, that align to the aims set out in the NHS Long Term Plan.
Kinomica are excited to see the following patents granted:
• KSEA (Kinase-substrate enrichment analysis) is now granted in Europe, USA and Japan.
• The database of kinase-substrate relationships granted in Europe with applications filed in the USA and Japan.
RSSL's in-depth MDR training is designed to help you and your team prepare for the new regulation challenges in order to facilitate a smooth transition. This includes learning how to interpret and navigate new regulations, determine device classification and understand conformity assessment routes.
Please click on the image below for the full OBN Update - we hope that you enjoy reading it!
AMSBIO's HYAL activity kit has enabled a collaborative team of international biomedical researchers** to investigate the expression and activity of hyaluronidases in intervertebral disc health and disease.
As the growing demand for personalised medicines continues, a recent report projects that the global growth of the Advanced Therapy Medical Products (ATMPs) market will also be boosted. RSSL has recognised this need and has created a training course perfectly suited to both those new to the field and those that have been working in the field for some time but have little understanding of the GMP expectations for this group of products.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.